This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
Biogen
Avis Budget Group
Cognizant Technology
Biogen BIIB | 0.00 | |
Avis Budget Group CAR | 0.00 | |
Cognizant Technology CTSH | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Needham analyst Ami Fadia upgraded Biogen Inc. (NASDAQ:BIIB) from Hold to Buy and announced a $255 price target. Biogen shares closed at $195.34 on Friday. See how other analysts view this stock.
- Wedbush analyst Steven Wahrhaftig upgraded Cognizant Technology Solutions Corporation (NASDAQ:CTSH) from Neutral to Outperform and boosted the price target from $56 to $70. Cognizant Tech shares closed at $53.21 on Friday. See how other analysts view this stock.
- Barclays analyst Dan Levy upgraded Avis Budget Group, Inc. (NASDAQ:CAR) from Underweight to Equal-Weight and raised the price target from $140 to $160. Avis Budget shares closed at $176.79 on Friday.
Considering buying BIIB stock? Here’s what analysts think:
Photo via Shutterstock
